コーパス検索結果 (right1)
通し番号をクリックするとPubMedの該当ページを表示します
1 ated pretransplantation and posttransplantation, with a low rate of serious adverse events.
2 None of the therapies was associated with an increased rate of serious adverse events.
3 due to limited response (70% colectomy at 3 years) and high rate of serious adverse events.
4 background therapies was associated with an increase in the rate of serious adverse events.
5 angiosuppressive therapy were both associated with a lower rate of serious adverse events.
6 mab, as compared with placebo, was associated with a higher rate of serious adverse events (24.4% vs. 15.3%), infections
7 50/r and dasabuvir with ribavirin was associated with a low rate of serious adverse events and a high rate of sustained v
9 with a very low rate of adverse events, an exceedingly low rate of serious adverse events, and an undetectable mortality
10 WBRT, although there was no evidence of a difference in the rate of serious adverse events between the two groups.
14 ts, ACTH compared with TCH was not associated with a higher rate of serious adverse events or hospitalizations, but it wa
15 Lixisenatide was not associated with a higher rate of serious adverse events or severe hypoglycemia, pancre
16 ts with compensated cirrhosis reported no deaths and a 1.1% rate of serious adverse events (primarily bleeding and severe
17 The primary safety objective was to determine whether the rate of serious adverse events related to device, procedure,
18 The two groups did not differ significantly in the rate of serious adverse events, though the risk of diarrhea w
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。